medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-1-148-156medsovet-25Research ArticleШкола педиатраSchool for pediatricianВедение детей с острым гастроэнтеритом на педиатрическом участке (рекомендации ESPGHAN-2014)Management of children with acute gastroenteritis in the pediatric district (recommendations of the ESPGHAN-2014)ГуариноА. .GuarinoA.noemail@neicon.ruЗахароваИ. Н.ZakharovaI. N.noemail@neicon.ruСугянН. Г.SugyanN. G.noemail@neicon.ruУниверситет Федерико IIРоссияUniversity of Naples Federico IIRussian FederationРоссийская медицинская академия последипломного образованияРоссияRussian Medical Academy of Postgraduate EducationRussian Federation20163012201611148156Copyright © Гуарино А..., Захарова И.Н., Сугян Н.Г., 20162016Гуарино А..., Захарова И.Н., Сугян Н.Г.Guarino A., Zakharova I.N., Sugyan N.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/25

Европейским обществом детских гастроэнтерологов, гепатологов и нутрициологов (ESPGHAN) совместно с Европейским обществом детских инфекционистов (ESPID) в 2008 г. опубликовано руководство по ведению детей с острым гастроэнтеритом (слайд 1) [1]. В 2014 г. в связи с появившимися новыми данными, полученными с учетом доказательной медицины, документ был обновлен [2].

In 2008, the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) in conjunction with the European Society for Paediatric Infectious Diseases (ESPID) published guidelines for the management of acute gastroenteritis in children [1] (Slide 5). When the new evidence-based data emerged in 2014, the document was updated. [2]

острый гастроэнтеритдиагностикаосложнениятерапияacute gastroenteritisdiagnosiscomplicationstherapyReferencesAlbano F, Bruzzese E, Bella A, et al. Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr, 2007, 166: 241-7.Albano F, Bruzzese E, Bella A, et al. Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr, 2007, 166: 241-7.Ouigley MA, Kelly YJ, Sacker A. Breastfeeding and hospitalization for diarrheal and respiratory infection in the United Kingdom Millennium Cohort Study. Pediatrics, 2007, 119: e837-42.Ouigley MA, Kelly YJ, Sacker A. Breastfeeding and hospitalization for diarrheal and respiratory infection in the United Kingdom Millennium Cohort Study. Pediatrics, 2007, 119: e837-42.Rosenfeldt V, Vesikari T, Pang XL et al. Viral etiology and incidence of acute gastroenteritis in young children attending day-care centers. Pediatr Infect Dis J, 2005, 24: 962-5.Rosenfeldt V, Vesikari T, Pang XL et al. Viral etiology and incidence of acute gastroenteritis in young children attending day-care centers. Pediatr Infect Dis J, 2005, 24: 962-5.Jonas A, Yahav J, Soudry A. Clinical features of viral and bacterial gastroenteritis in hospitalized children. Isr J Med Sci, 1982, 18: 753-9.Jonas A, Yahav J, Soudry A. Clinical features of viral and bacterial gastroenteritis in hospitalized children. Isr J Med Sci, 1982, 18: 753-9.Liu LI,Yang YJ, Kuo PH, et al. Diagnostic value of bacterial stool cultures and viral antigen tests based on clinical manifestations of acute gastroenteritis in pediatric patients. Eur J Clin Microbiol Infect Dis, 2005, 24: 559-61.Liu LI,Yang YJ, Kuo PH, et al. Diagnostic value of bacterial stool cultures and viral antigen tests based on clinical manifestations of acute gastroenteritis in pediatric patients. Eur J Clin Microbiol Infect Dis, 2005, 24: 559-61.Cadwgan AM, Watson WA, Laing RB, et al. Presenting clinical features and C-reactive protein in the prediction of a positive stool culture in patients with iarrhea. J Infect, 2000, 41: 159-61.Cadwgan AM, Watson WA, Laing RB, et al. Presenting clinical features and C-reactive protein in the prediction of a positive stool culture in patients with iarrhea. J Infect, 2000, 41: 159-61.Korczowski B, Szybist W. Serum procalcitonin and C-reactive protein in children with diarrhea of various aetiologies. Acta Paediatr, 2004, 93: 169-73.Korczowski B, Szybist W. Serum procalcitonin and C-reactive protein in children with diarrhea of various aetiologies. Acta Paediatr, 2004, 93: 169-73.The treatment of iarrhea-a manual for physicians and other senior health workers Geneva, Switzerland: World Health Organization, 2005.The treatment of iarrhea-a manual for physicians and other senior health workers Geneva, Switzerland: World Health Organization, 2005.Fortin J, Parent MA. Dehydration scoring system for infants. J Trop Pediatr Environ Child Health, 1978, 24: 110-4.Fortin J, Parent MA. Dehydration scoring system for infants. J Trop Pediatr Environ Child Health, 1978, 24: 110-4.Ruuska T, Vesikari T Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis, 1990, 22: 259-67.Ruuska T, Vesikari T Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis, 1990, 22: 259-67.Steiner MJ, DeWalt DA, Byerley JS. Is this child dehydrated? JAMA, 2004, 291: 2746-54.Steiner MJ, DeWalt DA, Byerley JS. Is this child dehydrated? JAMA, 2004, 291: 2746-54.Fonseca BK, Holdgate A, Craig JC. Enteral vs intravenous rehydration therapy for children with gastroenteritis: meta-analysis of randomized controlled trials. Arch pediatr Adolesc Med, 2004, 158: 483-90.Fonseca BK, Holdgate A, Craig JC. Enteral vs intravenous rehydration therapy for children with gastroenteritis: meta-analysis of randomized controlled trials. Arch pediatr Adolesc Med, 2004, 158: 483-90.Hahn S, Kim S, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhea in children. Cochrane Database Syst Rev, 2002, CD002847.Hahn S, Kim S, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhea in children. Cochrane Database Syst Rev, 2002, CD002847.Khan AM, Sarker SA, Alam NH, et al. Low osmolar oral rehydration salts solution in the treatment of acute watery iarrhea inneonates and young infants: a randomized, controlled clinical trial. J Health Popul Nutr, 2005, 23: 52-7.Khan AM, Sarker SA, Alam NH, et al. Low osmolar oral rehydration salts solution in the treatment of acute watery iarrhea inneonates and young infants: a randomized, controlled clinical trial. J Health Popul Nutr, 2005, 23: 52-7.Villarruel et al. Saccharomyces boulardii in acute childhood iarrhea: a randomized, placebo-controlled study. Acta Paediatrica, 2007 April, 96(4): 538-541.Villarruel et al. Saccharomyces boulardii in acute childhood iarrhea: a randomized, placebo-controlled study. Acta Paediatrica, 2007 April, 96(4): 538-541.Kurugol et al. Effects of Saccharomyces boulardii in Children with Acute Diarrhoea. Acta Paediatrica, 2005 Jan, 94(1): 44-47.Kurugol et al. Effects of Saccharomyces boulardii in Children with Acute Diarrhoea. Acta Paediatrica, 2005 Jan, 94(1): 44-47.Szajewska H1, Skorka A, Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther, 2007 Feb 1, 25(3): 257-64.Szajewska H1, Skorka A, Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther, 2007 Feb 1, 25(3): 257-64.Dinleyici E, Eren M, Ozen M, Yargic Z, Vandenplas Y Expert Opinion on Biological Therapy, 2012.Dinleyici E, Eren M, Ozen M, Yargic Z, Vandenplas Y Expert Opinion on Biological Therapy, 2012.Basualdo W, Arbo A. Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. Pediatr Infect Dis J, 2003, 22: 374-7.Basualdo W, Arbo A. Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. Pediatr Infect Dis J, 2003, 22: 374-7.Miron D, Torem M, Merom R et al. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis. Pediatr Infect Dis J, 2004, 23: 367-8.Miron D, Torem M, Merom R et al. Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis. Pediatr Infect Dis J, 2004, 23: 367-8.

The authors declare that there are no conflicts of interest present.